Your Messages Inbox
Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. 2008 Exclusive Survey—Earnings: Good news for primary care income 3. Medicare pay-for-reporting effort draws fire from frustrated doctors 4. Debunking Myths in the US Healthcare System 5. EGFR inhibitors as first-line therapy in advanced non-small cell lung cancer
Your Article Summary
See Latest ArticlesAcid Sphingomyelinase Inhibitors Normalize Pulmonary Ceramide and Inflammation in Cystic Fibrosis
American Journal of Respiratory Cell and Molecular Biology, 07/31/09
Becker KM et al. – The findings employing several structurally different Asm inhibitors identify Asm as primary target in the lung to reduce ceramide concentrations. Inhaling an Asm inhibitor may be a beneficial treatment for CF, with minimal adverse systemic effects.
Today in Basic Science/Genetics...keeping you current
Receive free subspecialty "5-minute updates" via email
Respiratory Viral RNA on Toys in Pediatric Office Waiting Rooms
The Pediatric Infectious Disease Journal, 11/16/09
Absence of inflammation and pneumonia during infection with non-pigmented Yersinia pestis reveals new role for the pgm locus in pathogenesis
Infection and Immunity, 10/30/09
Pattern of Antioxidant and DNA Repair Gene Expression in Normal Airway Epithelium Associated with Lung Cancer Diagnosis
Cancer Research, 11/17/09
Today in Cystic Fibrosis...keeping you current
Receive free subspecialty "5-minute updates" via email
Long-term pulmonary outcome after meconium ileus in cystic fibrosis
Pediatric Pulmonology, 11/17/09
Growth in children with cystic fibrosis-related diabetes
Pediatric Pulmonology, 11/09/09
Aminoglycoside therapy against Pseudomonas aeruginosa in cystic fibrosis: A review
Journal of Cystic Fibrosis , 11/24/09
Sponsor
Article Search
Sponsor